GT Biopharma Inc. Common Stock GTBP
$11.63
+35.08%
at last close
Analyst Consensus
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2024-12-02 | Roth MKMJonathan Aschoff |
Initiates coverage on | Buy | $11 |
| 2023-08-08 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $150 |
| 2023-08-07 | EF HuttonTony Butler |
Reiterates | Hold | $60 |
| 2023-06-05 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $150 |
| 2023-05-17 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $150 |
| 2023-05-16 | EF HuttonTony Butler |
Reiterates | Hold | $60 |
| 2023-04-03 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $150 |
| 2023-03-31 | EF HuttonTony Butler |
Reiterates | Hold | $60 |
| 2023-01-05 | EF HuttonTony Butler |
Initiates coverage on | Hold | $60 |
| 2022-09-13 | HC Wainwright & Co.Robert Burns |
Maintains | Buy | $750 → $150 |
| 2021-05-24 | HC Wainwright & Co.Robert Burns |
Initiates coverage on | Buy | $750 |
| 2021-04-13 | B. Riley Securities |
Initiates coverage on | Buy | $630 |
| 2021-03-17 | Roth CapitalTony Butler |
Initiates coverage on | Buy | $750 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $11.63
- Market Cap
- $15.54 million
- 52-Week Range
- $4.91 – $44.50
- Average Volume
- 63K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.